wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30243925-2CB79049-F841-49C5-BF16-789F89F05DA5
Q30243925-2CB79049-F841-49C5-BF16-789F89F05DA5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30243925-2CB79049-F841-49C5-BF16-789F89F05DA5
Treating adults with acute lymphocytic leukemia: new pharmacotherapy options.
P2860
Q30243925-2CB79049-F841-49C5-BF16-789F89F05DA5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30243925-2CB79049-F841-49C5-BF16-789F89F05DA5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6d5a2444b7c7a7ec1da984e2e2d25795ddbca182
P2860
Phase II trial of the anti-CD19 bispecific T cell-engager blinatumomab shows hematologic and molecular remissions in patients with relapsed or refractory B-precursor acute lymphoblastic leukemia.